Vector's (NZSE:VCT) stock is up by 4.6% over the past three months. However, its weak financial performance indicators makes us a bit doubtful if that trend could continue. Specifically, we decided to ...
The Centers for Disease Control and Prevention recently released a report showing that diseases from vectors, such as mosquitoes, ticks, and fleas, have tripled since 2004 in the U.S. The World Health ...
On the basis of these preclinical and clinical data and background, we conducted a phase I dose-escalation study of TG1041 in patients with metastatic or locally recurrent melanoma. The primary ...
Canada’s Vector Institute has assessed 11 leading AI models from around the world, using 16 performance benchmarks, including those pioneered by Vector researchers. The State of Evaluation study marks ...
Allogeneic hematopoietic stem-cell transplantation for X-linked severe combined immunodeficiency (SCID-X1) often fails to reconstitute immunity associated with T cells, B cells, and natural killer (NK ...
In its State of Evaluation study, Vector’s AI Engineering team assessed 11 leading LLMs from around the world, including both publicly available (‘open’) models such as DeepSeek-R1 and Cohere’s ...